Flavonoids in MASLD: preclinical mechanisms, pharmacological targets, and translational challenges
{{output}}
Metabolic dysfunction-associated steatotic liver disease (MASLD) has become the most prevalent chronic liver disease worldwide, yet no pharmacological therapy has achieved regulatory approval. Flavonoids, plant-derived polyphenols encompassing seven structural... ...